Explorer
Vaccine for kids to be available soon | India Chahta Hai (13.05.2021)
On May 12, the country's Drug Controller General of India (DCGI) has accepted the recommendation of the Subject Expert Committee and has approved the second and third clinical trials of India Biotech's Corona Vaccine Covaxin. This clinical trial will be done in the age group of 2 to 18 years. Watch India Chahta Hai to know more.
All Shows
India Chahta hai
![Dhami government came into action regarding registration of Madrasas](https://feeds.abplive.com/onecms/images/uploaded-images/2022/10/12/ffb7100bd0416346faa4170e751ea30e1665593631502406_original.jpg?impolicy=abp_cdn&imwidth=470)
Dhami government came into action regarding registration of Madrasas
![#](https://feeds.abplive.com/onecms/images/uploaded-images/2022/10/09/01cb1f37fd6e529fdd9b17d14353ec3a1665336029264406_original.jpg?impolicy=abp_cdn&imwidth=470)
Amid Russia - Ukraine Conflict, Is Vladimir Putin preparing to launch a nuclear attack?
![#](https://feeds.abplive.com/onecms/images/uploaded-images/2022/10/05/c4a134868d8a47122be66053a54e26d41664989524609406_original.jpg?impolicy=abp_cdn&imwidth=470)
Dussehra 2022 : Uddhav Thackeray's address to the public at Shivaji Park amid Dussehra Celebrations
![#](https://feeds.abplive.com/onecms/images/uploaded-images/2022/10/03/d1c5db8a5794dfc90c6f5382b7f7e33d1664819514900406_original.jpg?impolicy=abp_cdn&imwidth=470)
C-Voter Survey : Why do Muslims of Gujarat love PM Modi? | Gujarat Election
![#](https://feeds.abplive.com/onecms/images/uploaded-images/2022/09/30/e04abeb052a3860d5a6504c891eb990d1664558584868406_original.jpg?impolicy=abp_cdn&imwidth=470)
Watch Inside Story of Mallikarjun Kharge becoming a candidate | Congress President Election
Advertisement
Top Headlines
India
Delhi NCR
Cities
Cities
Advertisement
Advertisement
Trending News
![ABP Premium](https://cdn.abplive.com/imagebank/metaverse-mid.png)
Advertisement
![Prosenjit Nath](https://cdn.abplive.com/imagebank/editor.png)
Prosenjit NathThe writer is a technocrat, political analyst, and author.
Opinion